StreetAlpha.app
Home › Stocks › SCTX

Scribe Therapeutics, Inc. (SCTX)

Healthcare
$12.07
▼ −8.70%
LAST CLOSE · NOV 20

Scribe Therapeutics, Inc. (SCTX) is a Healthcare stock tracked by StreetAlpha. It last closed at $12.07 on Nov 20, down 8.70% on the day. The next earnings report for SCTX is expected around Thu, Feb 11, 2027, after the close. For the quarter ended Sep 2026, SCTX reported EPS of -$0.68. Over the last 12 months SCTX insiders bought $71.3M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is SCTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SCTX.
Next report
Feb 11
Estimated date · After the close
Reported EPS
-$0.68
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
How SCTX moved after its last 2 reports
Average move the session after a report ±2.0%
Nov 12, 2026After the close−3.7%
Sep 2, 2026After the close−0.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SCTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on SCTX: 0 upgrades, 0 downgrades, 0 initiations
HC WainwrightReiterated
Nov 21Buy 

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on SCTX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SCTX

Technical Analysis

SCTX · as of the Nov 20 close · updated each morning
Falling, nearing oversold

The stock is 31% below its 20 day and 62% below its 50 day average. Momentum is weak (RSI 31), near oversold. The nearest support is the 52 week low at $12.00, and the nearest resistance the Pivot at $12.49.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 16.2%/day
Key levels
$39.6052 week high+228.1%
$19.5650 day average+62.1%
$18.27Swing high (Oct 29)+51.4%
$15.8220 day average+31.1%
$12.98Pivot R1+7.5%
$12.49Pivot+3.5%
$12.07Last close
$12.0052 week low−0.6%
$11.58Pivot S1−4.1%
Indicators
RSI (14)30.56Weak, oversold below 30Neutral
MACD-1.52Below its signal lineBearish
Stochastic4.5Near the bottom of its rangeOversold
ADX (14)20.8Weak trend
Williams %R-98.9Oversold below −80, overbought above −20Oversold
CCI (20)-266.6Oversold below −100, overbought above 100Oversold
Rate of change−23.1%Change over 10 sessionsBearish
ATR (14)$1.95Typical daily range, 16.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for SCTX

What happened before

See how SCTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for SCTXHow many large options trades hit SCTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

SCTX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲63 buying vs 0 selling
  • ▲Held by funds +85.5 pts
  • ●Funds holding +63
  • ▲Superinvestors: 2 added, 0 cut
  • ●Put/call not meaningful
Q3 2026This quarterLast quarterChange
Funds holding63––
In funds' top 102––
Held by funds85.5%––
New / increased63 / 0––
Reduced / sold out0 / 0––
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SCTX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SCTX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$71.3M6 buys · 6 insiders
Sold$00 sales · 0 insiders
Cluster buy: 6 insiders bought $71.3M between Jul 23 and Jul 28.
2026-07 bought $71.3MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Jul 28Behzad AghazadehDirectorBuy2,391,238$15.16$36.3M
Jul 27Orbimed Advisors LLCDirectorBuy1,000,000$15.00$15.0M
Jul 27Carl L GordonDirectorBuy1,000,000$15.00$15.0M
Jul 27AH Bio Fund II, L.P.10% ownerBuy333,333$15.00$5.0M
Jul 23Svetlana LucasChief Business OfficerBuy3,000$15.00$45K
Jul 23David ParrotCFOBuy2,666$15.00$40K
Every insider buy and sale for SCTX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SCTX insider trades →

From SEC Form 4 filings by SCTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SCTX is in one of them and how their past SCTX trades turned out.

SCTX in the AI portfolios
Loading…

SCTX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SCTX in an article yet. Here's the latest on the wider market.

SCTX in the news